Ropes & Gray advised AbbVie on the deal. AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja) Umoja Biopharma announced two exclusive option and license agreements to develop multiple in-situ...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented Genesis Therapeutics in the fundraising, and Cooley represented Andreessen Horowitz (a16z) Bio + Health Tech Investments. Genesis Therapeutics announced that it has...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised Asia Alternatives on the transaction. Asia Alternatives, one of the largest independent Asian private equity fund-of-funds, announced the final close of $2...
You must be a Standard 1 Year member to access this content.
Ropes & Gray served as fund counsel to SkyKnight Capital on the transaction. SkyKnight Capital Fund III, L.P. (“Fund III”) announced its final close with $600 million...
You must be a Standard 1 Year member to access this content.
